These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8721554)

  • 1. Combination therapy in primary HIV infection.
    Perrin L; Hirschel B
    Antiviral Res; 1996 Jan; 29(1):87-9. PubMed ID: 8721554
    [No Abstract]   [Full Text] [Related]  

  • 2. Protease inhibitors at a glance...
    Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New guidelines set for occupational HIV exposure.
    Rowe PM
    Lancet; 1996 Jul; 348(9019):48. PubMed ID: 8691935
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of once-daily antiretroviral therapy.
    Boyle BA
    AIDS Read; 2002 Mar; 12(3):90-2, 95-6, 109. PubMed ID: 11966243
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimizing the new combination treatments.
    Hogan C
    GMHC Treat Issues; 1996 Aug; 10(8):11-2. PubMed ID: 11363718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral update.
    PI Perspect; 1996 Nov; (No 20):8-9. PubMed ID: 11363972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How HIV drugs work 101.
    Pietrandoni G
    Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
    [No Abstract]   [Full Text] [Related]  

  • 8. Consider these initial combination regimens.
    AIDS Alert; 2010 Apr; 25(4):40. PubMed ID: 20556895
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protease inhibitors].
    Tachikawa N
    Kansenshogaku Zasshi; 2005 Dec; 79(12):905-30. PubMed ID: 16444973
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated guidelines for occupational postexposure prophylaxis.
    del Rio C
    AIDS Clin Care; 2005 Dec; 17(12):114. PubMed ID: 16388540
    [No Abstract]   [Full Text] [Related]  

  • 11. No nukes please.
    TreatmentUpdate; 2002 Nov; 14(8):6. PubMed ID: 12501825
    [No Abstract]   [Full Text] [Related]  

  • 12. PI/NRTI "sparing" regimens for HIV infection. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Cohen C
    IAPAC Mon; 2001 Aug; 7(8):254-60. PubMed ID: 11708281
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights from the 3rd International Workshop on Clinical Pharmacology of HIV Therapy.
    TreatmentUpdate; 2002; 14(4):1-2. PubMed ID: 12064311
    [No Abstract]   [Full Text] [Related]  

  • 14. The ever-changing HIV treatment landscape.
    Berger DS
    Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
    [No Abstract]   [Full Text] [Related]  

  • 15. Rescue regimens: the value of protease-inhibitor boosting.
    Segal-Maurer S; Schütz M
    Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
    [No Abstract]   [Full Text] [Related]  

  • 16. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 17. Protease inhibitor combos.
    Newsline People AIDS Coalit N Y; 1998 Feb; ():36-7. PubMed ID: 11367448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy: how simple can you get?
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):3-7. PubMed ID: 11365906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing in on human immunodeficiency virus-1.
    Mellors JW
    Nat Med; 1996 Mar; 2(3):274-5. PubMed ID: 8612219
    [No Abstract]   [Full Text] [Related]  

  • 20. Focus on fat.
    TreatmentUpdate; 2002 Nov; 14(8):4. PubMed ID: 12501822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.